In an amyloid precursor protein (APP)/presenilin 1 (PS1) AD mouse model, antagonism of the CXCL10 receptor resulted in increased microglial phagocytosis of Aβ, reduced neuroinflammation, and attenuated behavioral deficits [77]. The gene discussed is APP; the disease is Alzheimer disease.